Susquehanna International Group
EVH icon

Susquehanna International Group’s Evolent Health EVH Stock Holding History

Susquehanna International Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,300
Closed -$141K – 13404
2025
Q4 		$141K Sell
35,300
-23,400
-40% -$130K ﹤0.01% 11222
2025
Q3 		$497K Sell
58,700
-34,000
-37% -$330K ﹤0.01% 8964
2025
Q2 		$1.04M Buy
92,700
+62,700
+209% +$576K ﹤0.01% 7315
2025
Q1 		$284K Sell
30,000
-219,800
-88% -$2.22M ﹤0.01% 10172
2024
Q4 		$2.81M Sell
249,800
-293,900
-54% -$5.17M ﹤0.01% 4599
2024
Q3 		$15.4M Buy
543,700
+222,700
+69% +$5.74M ﹤0.01% 2100
2024
Q2 		$6.14M Buy
321,000
+243,700
+315% +$6.22M ﹤0.01% 3127
2024
Q1 		$2.53M Sell
77,300
-91,400
-54% -$2.92M ﹤0.01% 4844
2023
Q4 		$5.57M Buy
168,700
+126,500
+300% +$3.58M ﹤0.01% 3530
2023
Q3 		$1.15M Buy
42,200
+34,000
+415% +$945K ﹤0.01% 6324
2023
Q2 		$248K Sell
8,200
-19,300
-70% -$624K ﹤0.01% 9826
2023
Q1 		$892K Buy
27,500
+1,200
+5% +$37.9K ﹤0.01% 7111
2022
Q4 		$739K Sell
26,300
-157,600
-86% -$4.52M ﹤0.01% 6879
2022
Q3 		$6.61M Buy
183,900
+136,200
+286% +$4.8M ﹤0.01% 2734
2022
Q2 		$1.47M Buy
47,700
+9,300
+24% +$271K ﹤0.01% 5589
2022
Q1 		$1.24M Buy
+38,400
New +$1.01M ﹤0.01% 6595
2021
Q4 		– Sell
-57,200
Closed -$1.77M – 13301
2021
Q3 		$1.77M Buy
57,200
+47,500
+490% +$1.14M ﹤0.01% 6096
2021
Q2 		$205K Sell
9,700
-16,600
-63% -$332K ﹤0.01% 11548
2021
Q1 		$531K Sell
26,300
-44,000
-63% -$837K ﹤0.01% 9325
2020
Q4 		$1.13M Buy
70,300
+7,200
+11% +$95.2K ﹤0.01% 6439
2020
Q3 		$783K Sell
63,100
-24,700
-28% -$290K ﹤0.01% 6711
2020
Q2 		$625K Buy
87,800
+7,400
+9% +$49.6K ﹤0.01% 6888
2020
Q1 		$437K Sell
80,400
-79,200
-50% -$707K ﹤0.01% 7214
2019
Q4 		$1.44M Buy
159,600
+128,300
+410% +$1.04M ﹤0.01% 4861
2019
Q3 		$225K Buy
31,300
+7,100
+29% +$51K ﹤0.01% 8872
2019
Q2 		$192K Sell
24,200
-135,800
-85% -$1.61M ﹤0.01% 9160
2019
Q1 		$2.01M Buy
160,000
+149,700
+1,453% +$2.37M ﹤0.01% 3725
2018
Q4 		$205K Sell
10,300
-39,400
-79% -$911K ﹤0.01% 7693
2018
Q3 		$1.41M Buy
+49,700
New +$1.19M ﹤0.01% 4593
2018
Q2 		– Sell
-48,400
Closed -$690K – 9796
2018
Q1 		$690K Buy
48,400
+4,100
+9% +$58.7K ﹤0.01% 5986
2017
Q4 		$545K Buy
44,300
+24,700
+126% +$348K ﹤0.01% 6465
2017
Q3 		$349K Sell
19,600
-10,200
-34% -$210K ﹤0.01% 7131
2017
Q2 		$755K Sell
29,800
-3,700
-11% -$89K ﹤0.01% 5858
2017
Q1 		$747K Buy
33,500
+15,800
+89% +$303K ﹤0.01% 5743
2016
Q4 		$262K Sell
17,700
-6,600
-27% -$130K ﹤0.01% 8210
2016
Q3 		$598K Buy
+24,300
New +$568K ﹤0.01% 5727

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's EVH Position: Q1 2026 in Review

Susquehanna International Group reduced its Evolent Health (EVH) stake by 58% in Q1 2026, selling an estimated $399K and leaving 91,537 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11622.

Susquehanna International Group first reported a position in EVH in Q3 2015 and has held it in 37 quarters since. The position peaked at $4.68M in Q3 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Susquehanna International Group held 91,537 shares of Evolent Health worth $209K as of Q1 2026.
  • Susquehanna International Group sold 125,810 Evolent Health shares in Q1 2026, an estimated $399K.
  • Evolent Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11622 holding.
  • Susquehanna International Group first reported a position in Evolent Health in Q3 2015 and has held it in 37 quarters since.
  • Susquehanna International Group's Evolent Health position peaked at $4.68M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.